Current status of application of convalescent plasma in acute viral infectious diseases and its prospect in therapy of COVID-19

Q4 Immunology and Microbiology 中国生物制品学杂志 Pub Date : 2020-01-01 DOI:10.13200/j.cnki.cjb.003023
X. M. Yang, J. Hou
{"title":"Current status of application of convalescent plasma in acute viral infectious diseases and its prospect in therapy of COVID-19","authors":"X. M. Yang, J. Hou","doi":"10.13200/j.cnki.cjb.003023","DOIUrl":null,"url":null,"abstract":"With the successful application of convalescent plasma (CP) in various acute viral infectious diseases, the unique advantage of the therapy has been paid more and more attentions Recently, a novel coronavirus named as 2019-nCoV (SARS-CoV-2) was discovered and identified in Wuhan, China Up to now, there has been no specific treatment for 2019-nCoV (SARS-CoV-2) infection This paper describes the current status of application of CP in Ebola, pandemic influenza, severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) as well as the prospect of CP in therapy of COVID-19","PeriodicalId":9990,"journal":{"name":"中国生物制品学杂志","volume":"28 1","pages":"241-245"},"PeriodicalIF":0.0000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中国生物制品学杂志","FirstCategoryId":"1089","ListUrlMain":"https://doi.org/10.13200/j.cnki.cjb.003023","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Immunology and Microbiology","Score":null,"Total":0}
引用次数: 1

Abstract

With the successful application of convalescent plasma (CP) in various acute viral infectious diseases, the unique advantage of the therapy has been paid more and more attentions Recently, a novel coronavirus named as 2019-nCoV (SARS-CoV-2) was discovered and identified in Wuhan, China Up to now, there has been no specific treatment for 2019-nCoV (SARS-CoV-2) infection This paper describes the current status of application of CP in Ebola, pandemic influenza, severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) as well as the prospect of CP in therapy of COVID-19
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
恢复期血浆在急性病毒性传染病中的应用现状及在新冠肺炎治疗中的应用前景
随着恢复期血浆(CP)在各种急性病毒性传染病中的成功应用,其独特的治疗优势越来越受到人们的重视。最近,在中国武汉发现并鉴定了一种名为2019-nCoV (SARS-CoV-2)的新型冠状病毒。到目前为止,还没有针对2019-nCoV (SARS-CoV-2)感染的特异性治疗方法。严重急性呼吸综合征(SARS)和中东呼吸综合征(MERS),以及CP治疗COVID-19的前景
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
中国生物制品学杂志
中国生物制品学杂志 Immunology and Microbiology-Applied Microbiology and Biotechnology
CiteScore
0.20
自引率
0.00%
发文量
7597
期刊最新文献
长链非编码RNA生长停滞特异性转录子5负调控核仁磷酸蛋白1对胃癌细胞顺铂耐药性的影响 Plackett-Burman实验和响应面法优化酵母源无血清培养基 碱性木聚糖酶高产菌株的筛选鉴定、酶学性质检测及培养条件优化 木香烃内酯对肝癌SMMC-7721细胞凋亡的影响及其作用机制 芍药苷对1-甲基-4-苯基-吡啶离子诱导PC12细胞损伤保护作用的机制
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1